OTHER CHARGES INCOME  NET Princeton Property Sale Sodium Sulfate Assets Sale Legal Matters Environmental Charges  Net at Operating Sites Other  Net On March 18  2008  we completed the sale of our 158-acre Princeton  research center to the Princeton HealthCare System. Gross proceeds from  the sale were $62.5 million and net proceeds after off sets  commissions  and fees totaled approximately $60 million. The gain on sale was  $29 million and is included in “Restructuring and other charges  (income)” in the consolidated statements of income for the year ended  December 31  2008. The gain on sale was reduced by the sale-leaseback  deferral described below. As part of the sale  we entered into a sale-leaseback under which certain  of the buildings sold to the Princeton HealthCare System were leased  back to us for a maximum period up to approximately three years.  The leaseback was accounted for as an operating lease and the present  value of the lease payments was deferred as part of the gain on sale.  At the time of the sale  we recorded a deferred gain in the amount of  $6.7 million. This amount was being recognized as a reduction of rent  expense over the term of the lease. During the third quarter of 2009  we  moved into our new research and development facility and as a result  we exited our leases with the Princeton HealthCare System. Th  e event  resulted in a net gain of $2.3 million since the amounts we deferred as  part of the gain on sale assumed a longer lease period. In February 2008  we completed the sale of Foret’s non-cogeneration  sodium sulfate assets. We recognized a gain on sale of these assets of  $3.6 million  which is included in “Restructuring and other charges  (income)” in the consolidated statements of income for the year  ended December 31  2008. Net proceeds from the transaction were  $16.7 million. We did not complete the sale of the sodium sulfate co-generation  facility at the time we sold the other sodium sulfate assets noted above.  We completed the sale of this asset in the third quarter of 2009 for a  gain of $1.0 million. During the year ended December 31  2010  we recorded $1.5 million  of net charges primarily related to a legal settlement associated with the  U.S. hydrogen peroxide matter in our Industrial Chemicals segment. During the year ended December 31  2009  we recorded an approximate  charge of $21.0 million in connection with the resolution of a regulatory  matter in our Industrial Chemicals Segment. We also recorded a  charge of $3.3 million related to the settlement of a legal matter in  our Industrial Chemicals segment and $5.6 million of other charges  primarily representing settlements with state authorities for property  claims and adjustments. During the year ended December 31  2008  we reached an agreement  in principle to settle a federal class action lawsuit  alleging violations of  antitrust laws involving our hydrogen peroxide product in our Industrial  Chemicals segment in the amount of $10.0 million. See Note 18 for further details. During the years ended December 31  2010  2009 and 2008 we  recorded $14.2 million  $20.2 million and $16.2 million of net charges   respectively  related to environmental remediation at continuing  operating sites. See Note 10 for additional details. In the second quarter of 2010  our Agricultural Products segment  acquired certain rights relating to an herbicide compound still under  development. We expensed $5.7 million for these rights. In 2006  our Agricultural Products segment entered into a development  agreement with a third-party company  whereby we were given the  right to develop further one of the third party company’s products in  certain geographic markets. This development agreement  representing  a fungicide project  was terminated by the Company in 2008. In 2007   our Agricultural Products segment entered into a collaboration and  license agreement with another third-party company for the purpose  of obtaining certain technology and intellectual property rights. In  2007  we acquired further rights under the development agreement   and in 2009 we extended our rights under the collaboration and license  agreement. We have recorded charges of $0.5 million  $2.0 million  and $1.0 million in 2010  2009 and 2008  respectively  under these  agreements representing payments to acquire and extend our rights  under these agreements. Remaining other charges for 2010  2009 and 2008 primarily represents  the accrual of interest associated with the European Commission fi ne  recorded during the year ended December 31  2006. See Note 18. 48 FMC CORPORATION    2010 Form 10K (in Millions) Year Ended December 31  2010 2009 2008 Princeton Property Sale $ — $(2.3) $(29.0) Sodium Sulfate Assets Sale — (1.0) (3.6) Legal Matters 1.5 29.9 10.0 Environmental Charges  Net at Operating Sites (see Note 10) 14.2 20.2 16.2 Other  net 9.0 4.5 3.8 OTHER CHARGES (INCOME)  NET $24.7 $51.3 $(2.6) PART II  NOTE 7 Restructuring and Other Charges (Income)